DK0835261T3 - Ionkanal - Google Patents

Ionkanal

Info

Publication number
DK0835261T3
DK0835261T3 DK96920970T DK96920970T DK0835261T3 DK 0835261 T3 DK0835261 T3 DK 0835261T3 DK 96920970 T DK96920970 T DK 96920970T DK 96920970 T DK96920970 T DK 96920970T DK 0835261 T3 DK0835261 T3 DK 0835261T3
Authority
DK
Denmark
Prior art keywords
sodium channel
novel
ion channel
tetrodotoxin
pain
Prior art date
Application number
DK96920970T
Other languages
Danish (da)
English (en)
Inventor
John Nicholas Wood
Armen Norakovitch Akopian
Original Assignee
Ionix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10776812&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0835261(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ionix Pharmaceuticals Ltd filed Critical Ionix Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK0835261T3 publication Critical patent/DK0835261T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Thin Film Transistor (AREA)
  • Optical Communication System (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
DK96920970T 1995-06-28 1996-06-25 Ionkanal DK0835261T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513180.1A GB9513180D0 (en) 1995-06-28 1995-06-28 Ion channel
PCT/GB1996/001523 WO1997001577A1 (fr) 1995-06-28 1996-06-25 Canal ionique

Publications (1)

Publication Number Publication Date
DK0835261T3 true DK0835261T3 (da) 2003-07-21

Family

ID=10776812

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96920970T DK0835261T3 (da) 1995-06-28 1996-06-25 Ionkanal

Country Status (12)

Country Link
US (3) US6451554B1 (fr)
EP (2) EP0835261B1 (fr)
JP (1) JPH11509090A (fr)
AT (1) ATE235512T1 (fr)
AU (1) AU721798B2 (fr)
CA (1) CA2221294A1 (fr)
DE (1) DE69626984T2 (fr)
DK (1) DK0835261T3 (fr)
ES (1) ES2196158T3 (fr)
GB (1) GB9513180D0 (fr)
PT (1) PT835261E (fr)
WO (1) WO1997001577A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513180D0 (en) * 1995-06-28 1995-08-30 Univ London Ion channel
US6184349B1 (en) * 1995-10-11 2001-02-06 Syntex (Usa) Inc. Cloned peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit
US6030810A (en) * 1997-02-26 2000-02-29 Delgado; Stephen Gregory Cloned tetrodotoxin-sensitive sodium channel α-subunit and a splice variant thereof
EP0884386A1 (fr) * 1997-05-30 1998-12-16 Synthelabo Canaux récepteurs de sodium
DE69836591T2 (de) * 1997-10-29 2007-09-20 Mcgill University, Montreal Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen
CH693031A5 (de) * 1997-11-20 2003-01-31 Hoffmann La Roche Nucleinsäure, die einen Nervengewebe-Natriumkanal kodiert.
AU1466199A (en) * 1997-11-20 1999-06-15 Medical College Of Georgia Research Institute, Inc. Cloning of a tetrodotoxin-resistant sodium channel alpha-subunit
JP2002509860A (ja) * 1998-01-29 2002-04-02 エール ユニヴァーシティ 後根神経節におけるナトリウムチャンネルの調節
US6573067B1 (en) * 1998-01-29 2003-06-03 Yale University Nucleic acid encoding sodium channels in dorsal root ganglia
GB9805793D0 (en) * 1998-03-18 1998-05-13 Glaxo Group Ltd Sodium ion channels
US20030228666A1 (en) * 1998-06-30 2003-12-11 Daewoong Pharmaceutical Co., Ltd. Novel human thrombopoietin mutein
WO2001038564A2 (fr) * 1999-11-26 2001-05-31 Mcgill University Loci pour epilepsie generalisee idiopathique, leurs mutations, et methode utilisant ceux-ci pour evaluer, diagnostiquer, pronostiquer ou traiter l'epilepsie
GB0006024D0 (en) * 2000-03-14 2000-05-03 Glaxo Group Ltd Altered ion channel proteins
WO2002002608A2 (fr) * 2000-07-05 2002-01-10 Neurosearch A/S Nouveau canal sodique (rnav1.5a) et utilisation
JP4701374B2 (ja) * 2000-08-04 2011-06-15 大学共同利用機関法人自然科学研究機構 ＮａＶ２チャネル遺伝子欠損非ヒト動物
CN1269482C (zh) * 2001-05-18 2006-08-16 威克斯医药有限公司 钠离子通道阻断剂和阿片类镇痛剂在制备用于对哺乳动物进行协同镇痛的药物中的应用
GB0120238D0 (en) * 2001-08-20 2001-10-10 Univ College Of London Sodium channel regulators and modulators
US7125676B2 (en) 2002-02-25 2006-10-24 Vanderbilt University Expression system for human brain-specific voltage-gated sodium channel, type 1
GB0211833D0 (en) * 2002-05-22 2002-07-03 Univ London Sodium channel regulators and modulators
WO2004087956A2 (fr) * 2003-04-02 2004-10-14 Ionix Pharmaceuticals Limited Lignees cellulaires
WO2005086934A2 (fr) * 2004-03-10 2005-09-22 Board Of Regents, The University Of Texas System Banques d'expression d'adnc enrichies et procedes de construction et d'utilisation correspondants
JP2008517629A (ja) * 2004-10-27 2008-05-29 シェーリング コーポレイション Ｎａｖ１．８の短い干渉核酸阻害のための組成物および方法
US7932058B2 (en) 2007-06-08 2011-04-26 Senomyx, Inc. Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
CN105445476B (zh) * 2015-12-17 2018-03-23 中山大学中山眼科中心 一种基于组织支架的三维视杯来源神经样细胞的钠离子通道检测方法
WO2023283618A1 (fr) * 2021-07-08 2023-01-12 Children's Medical Center Corporation Systèmes et procédés de distribution basés sur des nanostructures supramoléculaires

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009391A1 (fr) 1989-02-13 1990-08-23 Arch Development Corporation Acide nucleique codant une proteine de canaux de sodium
US5380836A (en) 1989-02-13 1995-01-10 Arch Development Corporation Nucleic acid encoding sodium channel protein
GB9513180D0 (en) * 1995-06-28 1995-08-30 Univ London Ion channel
US6184349B1 (en) * 1995-10-11 2001-02-06 Syntex (Usa) Inc. Cloned peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit

Also Published As

Publication number Publication date
US7112418B2 (en) 2006-09-26
DE69626984T2 (de) 2003-12-18
US20050221394A1 (en) 2005-10-06
AU6234596A (en) 1997-01-30
EP1281717A2 (fr) 2003-02-05
PT835261E (pt) 2003-08-29
US6451554B1 (en) 2002-09-17
EP0835261A1 (fr) 1998-04-15
EP0835261B1 (fr) 2003-03-26
JPH11509090A (ja) 1999-08-17
ATE235512T1 (de) 2003-04-15
DE69626984D1 (de) 2003-04-30
WO1997001577A1 (fr) 1997-01-16
US20030176648A1 (en) 2003-09-18
ES2196158T3 (es) 2003-12-16
GB9513180D0 (en) 1995-08-30
CA2221294A1 (fr) 1997-01-16
AU721798B2 (en) 2000-07-13
EP1281717A3 (fr) 2003-04-23

Similar Documents

Publication Publication Date Title
ATE235512T1 (de) Ionenkanal
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
ES8306324A1 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
PT830376E (pt) Processo de producao de eritropoietina isenta de proteinas animais
DK0666914T3 (da) Hidtil ukendt P-selectin-ligandprotein
DE69334211D1 (de) Multidrug resistenz gen
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
GR3019059T3 (en) Human MK gene and protein sequence
EP1609856A3 (fr) Composés renfermant des canaux ioniques modulés par des nucléotides cycliques d'origine cérébrale ou cardiaque, et leurs utilisations
DE3683447D1 (de) Verfahren zur herstellung von humanlysozym.
PT920501E (pt) Neuritina um neurogene
AU8811298A (en) Novel peptides and polypeptides useful for regenerating the nervous system
BR9610070A (pt) Sequência de ácido nucleico polipetídeos compostos antifibrótico e processo para tratar distúrbios ou doenças relacionadas com fibrose para usar a sequência de dna e para produzir c-proteinase recombinante
IL117316A0 (en) Acarbose genes process for the isolation thereof and their use
WO1995035373A3 (fr) Molecules d'acide nucleique codant la contactine humaine
GB2329896A (en) Enzyme and DNA sequence encoding same
GB2333527A (en) Therapeutic gene
IT8553207U1 (it) Operazione cosmetica per palpebre ad arcata sopraccigliare femminile in genere